Trial Profile
Investigation of the potential beneficial effects of cannabidiol in the management of oral-lingual-buccal dyskinesias using animal studies and a clinical trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2019
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary) ; Vitamin E
- Indications Drug-induced dyskinesia
- Focus Proof of concept; Therapeutic Use
- 01 Oct 2019 Status changed from active, no longer recruiting to completed.
- 15 May 2015 New trial record